Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cell Division|January 9, 2008
The ubiquitin E3 ligase activity of BRCA1 and its biological functionsWenwen Wu, Ayaka Koike, Takashi Takeshita, et al.
Cancer Chemotherapy and Pharmacology|March 11, 2009
Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agentsTakashi Takeshita, Wenwen Wu, Ayaka Koike, et al.
Breast Cancer (Tokyo, Japan)|May 22, 2009
Contemplating chemosensitivity of basal-like breast cancer based on BRCA1 dysfunctionTomohiko Ohta, Wenwen Wu, Ayaka Koike, et al.
Biological & Pharmaceutical Bulletin|April 3, 2024
Effect of Enoxaparin and Daikenchuto Coadministration on Hepatic Disorder Markers in Gynecological Cancer Patients after Abdominal SurgeryHiroaki Watanabe, Keita Hirai, Yuka Nakazawa, et al.
Cancer Research|August 18, 2010
Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugatesAyaka Koike, Hiroyuki Nishikawa, Wenwen Wu, et al.
Cancer Research|January 2, 2009
BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activityHiroyuki Nishikawa, Wenwen Wu, Ayaka Koike, et al.
Cancer Research|July 16, 2010
HERC2 is an E3 ligase that targets BRCA1 for degradationWenwen Wu, Ko Sato, Ayaka Koike, et al.
Breast Cancer Research : BCR|March 9, 2010
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteinsHideki Asakawa, Hirotaka Koizumi, Ayaka Koike, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|December 14, 2007
Putative tumor suppressor EDD interacts with and up-regulates APCRyuichi Ohshima, Tomohiko Ohta, Wenwen Wu, et al.
Pageof 2